Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Equine Pharmaceuticals And Supplements market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Equine Pharmaceuticals And Supplements market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Equine Pharmaceuticals And Supplements market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Equine Pharmaceuticals And Supplements products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Equine Pharmaceuticals And Supplements products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Equine Pharmaceuticals And Supplements market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Equine Pharmaceuticals And Supplements development has been the leading industry trend of Equine Pharmaceuticals And Supplements market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Equine Pharmaceuticals And Supplements Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Pharmaceuticals,Supplements, Other |
| By Application Outlook |
Thoroughbred Horse,Other Types of Horses |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Boehringer Ingelheim,Merck Animal Health,Zoetis,Bayer Animal Health,Elanco Animal Health,Dechra Veterinary Products,CEVA,Virbac,Norbrook Equine,Kyoritsu Seiyaku,Vetoquinol,Protexin Healthcare,Audevard,Ouro Fino Saude |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Boehringer Ingelheim
- Merck Animal Health
- Zoetis
- Bayer Animal Health
- Elanco Animal Health
- Dechra Veterinary Products
- CEVA
- Virbac
- Norbrook Equine
- Kyoritsu Seiyaku
- Vetoquinol
- Protexin Healthcare
- Audevard
- Ouro Fino Saude
Equine Pharmaceuticals And Supplements Market, By Type
- Pharmaceuticals
- Supplements
- Other
Equine Pharmaceuticals And Supplements Market, By Application
- Thoroughbred Horse
- Other Types of Horses
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Equine Pharmaceuticals and Supplements Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Equine Pharmaceuticals and Supplements Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Equine Pharmaceuticals and Supplements Industry Overview
2.1 Global Equine Pharmaceuticals and Supplements Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Equine Pharmaceuticals and Supplements Global Import Market Analysis
2.1.2 Equine Pharmaceuticals and Supplements Global Export Market Analysis
2.1.3 Equine Pharmaceuticals and Supplements Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3.2 Other Types of Horses
2.4.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Equine Pharmaceuticals and Supplements Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Equine Pharmaceuticals and Supplements Manufacturer Market Share
2.4.5 Top 10 Equine Pharmaceuticals and Supplements Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Equine Pharmaceuticals and Supplements Market
2.4.7 Key Manufacturers Equine Pharmaceuticals and Supplements Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Equine Pharmaceuticals and Supplements Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Equine Pharmaceuticals and Supplements Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Equine Pharmaceuticals and Supplements Market Size Categorized by Regions
4.1 Global Equine Pharmaceuticals and Supplements Revenue, Sales and Market Share by Regions
4.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Regions (2015-2020)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2015-2020)
4.2 Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.3 APAC Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.4 North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.5 South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5 Europe Equine Pharmaceuticals and Supplements Market Size Categorized by Countries
5.1 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
5.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020)
5.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020)
5.1.3 Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.1.4 UK Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.1.5 France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.1.6 Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.1.7 Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.1.8 Spain Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.2 Europe Equine Pharmaceuticals and Supplements Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
5.3.2 Europe Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
6 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size Categorized by Countries
6.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020)
6.1.3 China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.1.4 Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.1.5 Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.1.6 India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.1.8 Australia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Market Share by Application (2015-2020)
7 North America Equine Pharmaceuticals and Supplements Market Size Categorized by Countries
7.1 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
7.1.1 North America Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020)
7.1.2 North America Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020)
7.1.3 United States Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.1.4 Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.1.5 Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.2 North America Equine Pharmaceuticals and Supplements Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
7.3.2 North America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2015-2020)
7.4 North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
8 South America Equine Pharmaceuticals and Supplements Market Size Categorized by Countries
8.1 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
8.1.1 South America Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020)
8.1.2 South America Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020)
8.1.3 Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
8.2 South America Equine Pharmaceuticals and Supplements Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
8.3.2 South America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2015-2020)
8.4 South America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
9 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Categorized by Countries
9.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020)
9.1.3 GCC Countries Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.1.4 Turkey Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.1.5 Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.1.6 South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
10 Global Equine Pharmaceuticals and Supplements Market Segment by Type
10.1 Global Equine Pharmaceuticals and Supplements Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Type (2015-2020)
10.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2015-2020)
10.2 Pharmaceuticals Sales Growth Rate and Price
10.2.1 Global Pharmaceuticals Sales Growth Rate (2015-2020)
10.2.2 Global Pharmaceuticals Price (2015-2020)
10.3 Supplements Sales Growth Rate and Price
10.3.1 Global Supplements Sales Growth Rate (2015-2020)
10.3.2 Global Supplements Price (2015-2020)
11.1 Global Equine Pharmaceuticals and SupplementsSales Market Share by Application (2015-2020)
11.2 Thoroughbred Horse Sales Growth Rate (2015-2020)
11.3 Other Types of Horses Sales Growth Rate (2015-2020)
12.1 Global Equine Pharmaceuticals and Supplements Revenue, Sales and Growth Rate (2020-2027)
12.2 Equine Pharmaceuticals and Supplements Market Forecast by Regions (2020-2027)
12.2.1 Europe Equine Pharmaceuticals and Supplements Market Forecast (2020-2027)
12.2.2 APAC Equine Pharmaceuticals and Supplements Market Forecast (2020-2027)
12.2.3 North America Equine Pharmaceuticals and Supplements Market Forecast (2020-2027)
12.2.4 South America Equine Pharmaceuticals and Supplements Market Forecast (2020-2027)
12.2.5 Middle East & Africa Equine Pharmaceuticals and Supplements Market Forecast (2020-2027)
12.3 Equine Pharmaceuticals and Supplements Market Forecast by Type (2020-2027)
12.3.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2020-2027)
12.3.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2020-2027)
12.4 Equine Pharmaceuticals and Supplements Market Forecast by Application (2020-2027)
12.4.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2020-2027)
12.4.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2020-2027)
13 Analysis of Equine Pharmaceuticals and Supplements Industry Key Manufacturers
13.1 Boehringer Ingelheim
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Boehringer Ingelheim News
13.2 Merck Animal Health
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Merck Animal Health News
13.3 Zoetis
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Zoetis Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Zoetis News
13.4 Bayer Animal Health
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Bayer Animal Health News
13.5 Elanco Animal Health
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Elanco Animal Health News
13.6 Dechra Veterinary Products
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Dechra Veterinary Products News
13.7 CEVA
13.7.1 Company Details
13.7.2 Product Information
13.7.3 CEVA Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 CEVA News
13.8 Virbac
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Virbac Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Virbac News
13.9 Norbrook Equine
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Norbrook Equine News
13.10 Kyoritsu Seiyaku
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Kyoritsu Seiyaku News
13.11 Vetoquinol
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Vetoquinol News
13.12 Protexin Healthcare
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Protexin Healthcare News
13.13 Audevard
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Audevard Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Audevard News
13.14 Ouro Fino Saude
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 Ouro Fino Saude News
15 Appendix